Clinical Trials in Los Angeles

Showing 681-700 of 8,055 trials

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

NCT05462873

To characterize safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of QEQ278 in adult patients with advanced/metastatic non-small cell lung cancer, esophageal squamous cell carcinoma, renal cell carcinoma, and human papilloma virus associated head and neck squamous cell carcinoma.

Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellEsophageal Squamous Cell Carcinoma+1 more

Novartis Pharmaceuticals30 participantsStarted Apr 2023

Los Angeles, California, United States • Fort Myers, Florida, United States • Boston, Massachusetts, United States +9 more locations

ACTIVE_NOT_RECRUITING< 1 mile

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients

NCT04687358

The registry will focus on furthering the understanding of the natural history of recurrent pericarditis (RP), as well as document RP-related clinical, health-related quality of life (HRQoL), and economic burden and will assist the medical community to refine or develop data-driven recommendations for clinical management of RP patients to optimize clinical outcomes. It also aims to generate data in support of the impact of rilonacept on clinical outcomes in a real-world population.

Recurrent Pericarditis

Kiniksa Pharmaceuticals International, plc500 participantsStarted Mar 2021

Anchorage, Alaska, United States • Tucson, Arizona, United States • La Jolla, California, United States +26 more locations

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients

Find Trials by Condition in Los Angeles

Eliminating Monitor Overuse Trial (EMO Trial)

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

Antibacterial Mouthwash for Pharyngeal Gonorrhea Prevention

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED

Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)